Insider Shareholders with Direct Ownership of Jounce Therapeutics, Inc. (JNCE)
This section provides a comprehensive overview of the insiders with direct ownership of Jounce Therapeutics, Inc. (JNCE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Jounce Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Third Rock Ventures Ii, L.P.
> 10% Shareholder |
0 | 7,532,520 | 2,697,829 $0 | 8 |
Sep 15, 2021
Reduced 39.35%
|
|
Third Rock Ventures Iii, L.P.
> 10% Shareholder |
0 | 1,900,000 | 1,148,780 $0 | 1 |
Nov 12, 2021
Reduced 62.32%
|
|
Hugh M Cole
Chief Operating Officer |
99,200 | 50,526 | 110,082 $0 | 11 |
Jan 10, 2023
Reduced 7.7%
|
|
Elizabeth Trehu
Chief Medical Officer |
69,750 | 42,966 | 103,417 $0 | 16 |
Jan 10, 2023
Reduced 4.72%
|
|
Robert Kamen
Director |
0 | 60,975 | 20,000 $0 | 1 |
Jun 24, 2022
Added 50.0%
|
|
Concentra Biosciences, Llc
> 10% Shareholder |
10,000 | 0 | 10,000 $0 | 1 |
May 03, 2023
Added 50.0%
|
|
John Duncan Higgons
Director |
0 | 2,300 | 9,713 $0 | 5 |
Apr 15, 2021
Reduced 2.02%
|
|
Richard /Ca/ Murray
Director |
290,000 | 452,369 | 1 $0 | 19 |
May 03, 2023
Reduced 100.0%
|
|
Perry A Karsen
Director |
0 | 5,000 | 0 $0 | 1 |
May 03, 2023
Reduced 100.0%
|
|
Kimberlee C Drapkin
President, CFO and Treasurer |
67,050 | 128,758 | 0 $0 | 13 |
May 03, 2023
Reduced 100.0%
|